is the fda banning compounded semaglutide moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compounded Semaglutide: Legal & Safe
Description
These check-ins are essential for adjusting dosage and ensuring the treatment is both safe and effective

Im so nauseous, Im on Ozempic, she said

Hims & Hers expects at least $725 million in revenue from its weight-loss services alone in 2025

MARKET ECOSYSTEM The GLP-1 agonists ecosystem encompasses a network of interdependent stakeholders, including drug manufacturers, contract research and manufacturing organizations, healthcare providers, and end users

J Headache Pain 2025;26:46

This includes procedures that use anesthesia and sedation
